7619 related articles for article (PubMed ID: 1854213)
1. [Predictability of preclinical evaluation of anticancer drugs by human gastrointestinal cancer--nude mouse panel].
Fujita M; Fujita F; Sakamoto Y; Sugimoto T; Shimozuma K; Taguchi T
Gan To Kagaku Ryoho; 1991 Jul; 18(9):1429-37. PubMed ID: 1854213
[TBL] [Abstract][Full Text] [Related]
2. [Application to chemosensitivity tests of the human tumor-nude mouse system and subrenal capsule assay system].
Fujita M; Fujita F; Shimozuma K; Sakamoto Y; Kusuyama T; Usugane M; Origasa H; Taguchi T
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1227-34. PubMed ID: 3729446
[TBL] [Abstract][Full Text] [Related]
3. [Application of nude mouse-human cancer xenograft system for sensitivity test of anticancer drugs].
Fujita M; Taguchi T
Gan To Kagaku Ryoho; 1982 Apr; 9(4):606-15. PubMed ID: 7184418
[TBL] [Abstract][Full Text] [Related]
4. [Chemosensitivity of human gastrointestinal and breast cancer xenografts in nude mice].
Fujita F; Fujita M; Kimoto Y; Shimozuma K; Taguchi T
Gan To Kagaku Ryoho; 1985 Feb; 12(2):353-61. PubMed ID: 3970556
[TBL] [Abstract][Full Text] [Related]
5. Human tumor xenografts in the nude mouse and their value as test models in anticancer drug development (review).
Winograd B; Boven E; Lobbezoo MW; Pinedo HM
In Vivo; 1987; 1(1):1-13. PubMed ID: 2979758
[TBL] [Abstract][Full Text] [Related]
6. [Antitumor activity of HO-221, a derivative of benzoylphenylurea against human cancer xenografts in nude mice].
Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2255-61. PubMed ID: 1929446
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of response rates to various antitumor agents of human gastric tumors implanted in nude mouse.
Inaba M; Tashiro T; Kobayashi T; Fujimoto S; Sakurai Y; Maruo K; Ohnishi Y; Ueyama Y; Nomura T
Jpn J Cancer Res; 1986 Feb; 77(2):190-6. PubMed ID: 3082831
[TBL] [Abstract][Full Text] [Related]
8. Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study.
Boven E; Winograd B; Berger DP; Dumont MP; Braakhuis BJ; Fodstad O; Langdon S; Fiebig HH
Cancer Res; 1992 Nov; 52(21):5940-7. PubMed ID: 1394220
[TBL] [Abstract][Full Text] [Related]
9. Utilization of nude mice in research on human cancer--screening system of anticancer agents using human tumor xenografts in nude mice.
Ueyama Y
Prog Clin Biol Res; 1987; 229():287-310. PubMed ID: 3601990
[TBL] [Abstract][Full Text] [Related]
10. Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation.
Noso Y; Niimi K; Nishiyama M; Hirabayashi N; Toge T; Niimoto M; Hattori T
Cancer Res; 1987 Dec; 47(23):6418-22. PubMed ID: 3677085
[TBL] [Abstract][Full Text] [Related]
11. [Experimental chemotherapy of human gastrointestinal and breast cancers in nude mice and its correlation to clinical effect].
Fujita M; Fujita F; Taguchi T
Gan No Rinsho; 1984 Jul; 30(9 Suppl):1168-74. PubMed ID: 6433068
[TBL] [Abstract][Full Text] [Related]
12. Development of a panel of 15 human ovarian cancer xenografts for drug screening and determination of the role of the glutathione detoxification system.
Kolfschoten GM; Pinedo HM; Scheffer PG; Schlüper HM; Erkelens CA; Boven E
Gynecol Oncol; 2000 Mar; 76(3):362-8. PubMed ID: 10684711
[TBL] [Abstract][Full Text] [Related]
13. [Combination chemotherapy of HO-221, a derivative of benzoylphenylurea with various anticancer agents against human cancer xenografts in nude mice].
Fujita F; Fujita M; Inaba H; Sugimoto T; Okuyama Y; Taguchi T
Gan To Kagaku Ryoho; 1991 Oct; 18(13):2263-70. PubMed ID: 1929447
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines.
Glinsky GV; Price JE; Glinsky VV; Mossine VV; Kiriakova G; Metcalf JB
Cancer Res; 1996 Dec; 56(23):5319-24. PubMed ID: 8968076
[TBL] [Abstract][Full Text] [Related]
15. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
Taetle R; Rosen F; Abramson I; Venditti J; Howell S
Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
[TBL] [Abstract][Full Text] [Related]
16. Preclinical evaluation of the anticancer activity and toxicity of 9-nitro-20(S)-camptothecin (Rubitecan).
Giovanella BC; Stehlin JS; Hinz HR; Kozielski AJ; Harris NJ; Vardeman DM
Int J Oncol; 2002 Jan; 20(1):81-8. PubMed ID: 11743646
[TBL] [Abstract][Full Text] [Related]
17. Of mice and men: values and liabilities of the athymic nude mouse model in anticancer drug development.
Kelland LR
Eur J Cancer; 2004 Apr; 40(6):827-36. PubMed ID: 15120038
[TBL] [Abstract][Full Text] [Related]
18. [Preclinical screening of chemotherapeutic and endocrine agents using human tumor xenografts--nude mouse system].
Kubota T; Ishibiki K; Abe O
Gan To Kagaku Ryoho; 1991 Jul; 18(9):1439-47. PubMed ID: 1854214
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of ZD1694 (tomudex) against human head and neck cancer in nude mouse models: role of dosing schedule and plasma thymidine.
Cao S; McGuire JJ; Rustum YM
Clin Cancer Res; 1999 Jul; 5(7):1925-34. PubMed ID: 10430100
[TBL] [Abstract][Full Text] [Related]
20. [Accordance of the chemosensitivity between clinical specimens and their xenografts in nude mice by SDI test and the value of in vivo chemosensitivity test using nude mice].
Sakamoto Y; Fujita M; Goi M; Tsukamoto F; Sugimoto T; Okuyama Y; Rhi M; Kusuyama T; Fujita F
Gan To Kagaku Ryoho; 1993 Mar; 20(4):447-54. PubMed ID: 8452382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
